4-Amino-3-fluoropyridine

We are 4-Amino-3-fluoropyridine CAS:2247-88-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:  4-Amino-3-fluoropyridine
CAS.NO:2247-88-3
Synonyms:3-fluoropyridin-4-amine;
4-AMino-3-fluoropyridine;
Molecular Formula:C5H5FN2
Molecular Weight:112.10500
 
Physical and Chemical Properties:
Density:1.3±0.1 g/cm3
Melting point:74-77°C
Boiling point:217.1±20.0 °C at 760 mmHg
Flash point:85.1±21.8 °C
Index of Refraction:1.554
 
Specification:
Appearance: Yellow crystals
Purity:≥99.0%
 
Packing:Aluminum Foil Bag ,Fluoride Bottle ,25KG/Fiber Drum,
Storage:Store in a tightly closed container. Store in a cool, dry
Application:  used in the pharmaceutical intermediate

4-Amino-3-fluoropyridine


Related News: “CAR T-cell therapy continues to deliver remarkable outcomes for patients with hematologic malignancies, and next-generation approaches are needed to enable broad and timely patient access and reduce the cost and complexity of therapy,” said Scott Wolchko, President and Chief Executive Officer of Fate Therapeutics.Bis(2,6-difluoro-3-(1-hydropyrrol-1-yl)phenyl)titanocene CAS:125051-32-3 Most foreign drugmakers offered Beijing the lowest prices globally in a recent round of negotiations in order to get some of their new products included in national insurance program, a move that will help them gain access to more patients in less-affluent cities, officials said on Thursday.DL-monohidrato de hidrocloruro de arginina CAS:332360-01-7 Most foreign drugmakers offered Beijing the lowest prices globally in a recent round of negotiations in order to get some of their new products included in national insurance program, a move that will help them gain access to more patients in less-affluent cities, officials said on Thursday.1-bromo-8-yodonaftaleno CAS:4044-58-0 Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).An effective treatment for Alzheimer’s, which is estimated in 60%-70% of around 50 million dementia cases worldwide, could become one of the best-selling drugs globally.

Related Products
Product Name
4,4′-Dichlorodiphenyl sulfone View Details
2-Amino-5-bromopyridine View Details
2,4-Diphenyl-6-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3,5-triazine View Details
N-(3-trimethoxysilylpropyl)aniline manufacturer 1,2,3,4-Tetrahydro-1,1,4,4,6-pentamethylnaphthalene manufacturer 1-Fluoro-3-bromopropane manufacturer 2R,3R)-rel-1-(Dimethylamino)-3-(3-methoxyphenyl)-2-methylpentan-3-ol hydrochloride manufacturer 2,3-Dimethylbromobenzene manufacturer